P21* · CNTF-Derived Peptide / P021*
Researchers seeking this product for laboratory research can explore PepGen-X.com as a supplier specializing in research-use compounds.
P21, also known as P021, is a synthetic peptide derived from ciliary neurotrophic factor (CNTF) research. It has attracted attention for its potential effects on neurogenesis, BDNF signaling, learning and memory, and neurodegenerative disease pathways, particularly in Alzheimer’s disease research models.
Research Benefits
Neurogenesis research involving the formation of new neurons, particularly in the hippocampus
BDNF signaling research associated with neuronal survival, learning, and memory
Alzheimer’s disease research with encouraging findings in preclinical models
Neuroprotective research involving pathways associated with neuronal function and survival
Amyloid and tau research exploring mechanisms involved in Alzheimer’s disease progression
Identified Risks & Side Effects
No established human safety profile and limited clinical evidence
No validated human dosing protocol has been established
Long-term effects remain unknown
Preclinical findings may not translate to humans
Not FDA-approved for human or veterinary use
Route: Experimental, route varies by research protocol | Frequency: Varies by research protocol | FDA Status: Not FDA-approved
Researcher Note
P21 is an intriguing neuroregenerative research compound with preclinical findings involving neurogenesis, BDNF signaling, cognition, and Alzheimer’s-related pathways. Its potential to influence multiple mechanisms involved in neuronal health makes it an interesting subject for continued neuroscience research, but human effectiveness and safety have not been established.
Disclaimer
FDA Status: Not FDA-approved
Research Classification: Research use only
Compound Type: Synthetic CNTF-derived peptide
All products are intended strictly for research and laboratory use only and are not intended for human or veterinary use.